We treated B16-F10 tumor-bearing mice with PBS plus IgG isotype CTRL (IgG2a), AIL plus IgG2a, PBS plus anti-PD-L1 mAb or AIL plus anti-PD-L1 mAb. This evidence concerns the gene CD274 and neoplasm.